Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating an update to the page content. It does not appear to modify the study details or other substantive content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a maintenance or deployment change rather than a modification to the study record.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Ewing sarcoma and Malignant fibrous histiocytoma to the page's conditions/keywords.SummaryDifference0.1%

- Check73 days agoChange DetectedAngiosarcoma was added as a MeSH term and a 2026 publication (IMMUNOSARC II Master Trial) was added to Publications; the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page footer. No changes to core study content or user-visible functionality.SummaryDifference0.0%

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.